Cellwise(SH:688325)2025-04-24 14:00Financial Performance - The company's operating revenue for Q1 2025 reached ¥91,259,329.15, representing a year-on-year increase of 42.83% compared to ¥63,894,462.49 in the same period last year[4] - Net profit attributable to shareholders was ¥15,609,631.28, a significant increase of 110.43% from ¥7,417,930.69 in the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥14,290,018.61, reflecting a 131.15% increase from ¥6,182,171.21 year-on-year[4] - Basic earnings per share rose to ¥0.1898, up 111.12% from ¥0.0899 in the same period last year[4] - Total operating revenue for Q1 2025 reached ¥91,259,329.15, a 42.8% increase from ¥63,894,462.49 in Q1 2024[22] - Net profit for Q1 2025 was ¥15,609,631.28, compared to ¥7,417,930.69 in Q1 2024, indicating a growth of 110.4% year-over-year[23] - The total comprehensive income for the period reached CNY 15,612,486.62, a significant increase from CNY 7,416,395.08 in the previous year, reflecting a growth of approximately 110%[24] - Basic earnings per share (EPS) improved to CNY 0.1898, up from CNY 0.0899, representing an increase of about 111% year-over-year[24] Research and Development - The company invested ¥30,997,559.63 in R&D, which is 33.97% of its operating revenue, showing a 29.01% increase in R&D investment compared to the previous year[5] - Research and development expenses for Q1 2025 amounted to ¥30,997,559.63, an increase from ¥24,027,216.08 in Q1 2024, highlighting the company's commitment to innovation[23] Cash Flow and Assets - The net cash flow from operating activities was negative at -¥17,808,630.97, a decline of 193.61% compared to a positive cash flow of ¥19,025,026.07 in the same period last year[4] - Cash and cash equivalents as of March 31, 2025, amount to ¥307,171,550.41, down from ¥327,932,148.56 as of December 31, 2024[15] - The company's cash and cash equivalents saw a significant increase, with total current assets reaching ¥804,579,165.96, compared to ¥761,011,399.47 previously, marking a growth of 5.1%[19] - Cash inflow from investment activities totaled CNY 759,768,954.16, compared to CNY 493,387,513.95 in the previous year, marking an increase of approximately 54%[27] - The net cash flow from investment activities was negative at CNY -33,771,827.76, a decline from a positive CNY 259,445,710.96 in the previous year[27] - Total cash outflow from operating activities was CNY 117,510,728.03, compared to CNY 64,330,959.58 in the previous year, indicating an increase of about 83%[27] Shareholder Information - Total number of common shareholders at the end of the reporting period is 8,660[11] - The largest shareholder, Dongguan Weitu Investment Management Partnership, holds 17,610,600 shares, representing 20.73% of total shares[11] - The second largest shareholder, Shanghai Wuyuefeng Integrated Circuit Equity Investment Partnership, holds 9,778,735 shares, representing 11.51% of total shares[11] - The company has a total of 2,697,402 shares repurchased, accounting for 3.18% of the total share capital as of March 31, 2025[13] Liabilities and Equity - Total liabilities increased to ¥104,755,971.20 from ¥70,679,646.76, reflecting a rise of 48.1%[20] - The total equity attributable to shareholders increased to ¥1,733,760,598.50 from ¥1,711,977,281.93, reflecting a growth of 1.3%[20] Profitability - The company reported a gross profit of ¥5,750,030.55 for Q1 2025, compared to ¥1,757,044.61 in Q1 2024, indicating a substantial improvement in profitability[22] - The company recorded a financial income of ¥794,766.07 in Q1 2025, down from ¥1,264,769.40 in Q1 2024, indicating a decrease in financial returns[23] Future Outlook - The company attributed the revenue growth to increased market demand, product expansion, and enhanced customer resource accumulation[8] - The company plans to continue expanding its product offerings and market share to sustain growth in the future[8]